IP Library Granted Patent US 12,427,303
Granted Patent B2
US 12,427,303 · App. 17/685,186 · Granted Sep 30, 2025

Bioelectronic lens (e-lens) system for electrical stimulation and neuroprotection of the retina

Inventors: Mark S. Humayun (Glendale, CA); Gianluca Lazzi (Los Angeles, CA); Bodour Salhia (Los Angeles, CA); Manjunath Machnoor (Los Angeles, CA); Javad Paknahad (Los Angeles, CA); Alejandra Gonzalez-Calle (Los Angeles, CA); Ben Yi Tew (Los Angeles, CA)
Assignee: University of Southern California
A61N1/0464A61N1/0456A61N1/0492A61N1/0543A61N1/14A61N1/40
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,427,303
App. No.
17/685,186
Granted
Sep 30, 2025
Kind
B2
Abstract

Bioelectronic lens (E-lens) systems for inducing neuroprotective changes in neurons, in particular the retina. A system may include a stimulating electrode configured to be placed on an eye or skin around the eye. The system may further include a return electrode configured such that voltage distribution is focalized to the eye and induced electric fields to an area of interest on the eye or on the skin around the eye are maximized. The electric fields provide neuroprotection and reinnervation.

Claims (36)

1. A system for providing electrical stimulation, comprising:

a circuit configured to generate and wirelessly transmit a charge balanced and load independent stimulation waveform;

a battery-less passive receiver coil configured to wirelessly receive the stimulation waveform;

a first stimulating electrode electrically connected to the battery-less passive receiver coil and configured to be placed on a first portion of an eye of a patient and to receive the stimulation waveform;

a return electrode electrically connected to the battery-less passive receiver coil and configured to be placed on a second portion of the eye such that current or voltage distribution is focalized to the eye and induced electric fields to an area of interest on or into the eye are maximized, wherein the electric fields provide neuroprotection and reinnervation;

a ground electrically connected to the first stimulating electrode or the return electrode, the ground configured to be placed on a head of the patient, on skin adjacent to the eye or a non-stimulated eye or on a temporal area of the eye or the non-stimulated eye to induce the electric fields; and

a passive electrode not electrically connected to the battery-less passive receiver coil and configured to be placed on the head of the patient to induce the electric fields in a brain and/or an optic nerve of the patient.

2. The system of claim 1 , wherein the stimulation waveform is of long pulse durations to stimulate the eye and induce the electric fields to create epigenetic changes.

3. The system of claim 1 , wherein responses of retinal neurons to transcorneal electrical stimulation of various stimulus parameters are analyzed.

4. The system of claim 1 , wherein the area of interest on the eye includes a retina and an optic nerve, a ciliary body, a lacrimal gland, or a cornea including corneal nerves.

5. The system of claim 1 , further comprising:

a second stimulating electrode electrically connected to the battery-less passive receiver coil,

wherein the circuit is further configured to independently control stimulation of the first stimulating electrode and the second stimulating electrode from a transmitter end.

6. The system of claim 1 , further comprising a power source configured to supply power to the system.

7. The system of claim 6 , wherein the power source is a battery configured to be placed on the eye, a temporal site of the eye, eyeglasses, a head of the patient, or behind an ear of the patient.

8. A system for providing electrical stimulation, comprising:

a circuit configured to generate or receive a stimulation waveform;

a stimulating electrode electrically connected to the circuit and configured to be placed on a first portion of an eye of a patient;

a return electrode electrically connected to the circuit and configured to be placed on a second portion of the eye, the second portion being posterior to the first portion, such that voltage distribution is focalized to a central nervous system (CNS) and induced electric fields to an area of interest are maximized; and

a passive electrode not electrically connected to the circuit and configured to be placed on a forehead or a back of a head of the patient to induce the electric fields in layers of the CNS,

wherein the electric fields provide neuroprotection and reinnervation.

9. The system of claim 8 , wherein a symmetric biphasic charge-balanced waveform of long pulse durations is used to stimulate the eye and induce the electric fields to create epigenetic changes in the CNS.

10. The system of claim 8 , wherein the area of interest includes later geniculate, visual cortex, superior colliculus, motor cortex, frontal cortex, sensory cortex, other visual cortical areas, hippocampus, other subcortical regions, brainstem, or areas associated with the brainstem.

11. A system for providing electrical stimulation, comprising:

a circuit configured to generate and wirelessly transmit a symmetric biphasic charge-balanced waveform;

a battery-less passive receiver coil configured to wirelessly receive the symmetric biphasic charge-balanced waveform;

a stimulating electrode electrically connected to the battery-less passive receiver coil and configured to be placed on a first portion of an eye of a patient;

a return electrode electrically connected to the battery-less passive receiver coil and configured to be placed on a second portion of the eye such that a current density distribution is maximized along an optic nerve and in a superior colliculus; and

a passive electrode not electrically connected to the battery-less passive receiver coil and configured to be placed on a head of the patient to induce the electric fields in a brain and/or the optic nerve of the patient.

12. The system of claim 1 , wherein the first portion is adjacent to the second portion.

13. The system of claim 1 , further comprising one or more resonating capacitors electrically connected to the battery-less passive receiver coil.

14. The system of claim 8 , wherein the circuit includes a battery-less passive receiver coil electrically connected to the stimulating electrode and configured to wirelessly receive a symmetric biphasic charge-balanced waveform.

15. The system of claim 14 , further comprising one or more resonating capacitors electrically connected to the battery-less passive receiver coil.

16. The system of claim 11 , further comprising a contact lens configured to be placed on the eye and to house the battery-less passive receiver coil.

17. The system of claim 16 , further comprising one or more resonating capacitors electrically connected to the battery-less passive receiver coil.

18. The system of claim 1 , wherein the passive electrode is not electrically connected to the stimulating electrode and is not electrically connected to the return electrode.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 4, 2025
From: HUMAYUN, MARK S.; LAZZI, GIANLUCA; SALHIA, BODOUR; MACHNOOR, MANJUNATH; PAKNAHAD, JAVAD; GONZALEZ-CALLE, ALEJANDRA; TEW, BEN YI
To: UNIVERSITY OF SOUTHERN CALIFORNIA
Reel/Frame 071320/0888 →
CONFIRMATORY LICENSE Recorded Feb 12, 2025
From: UNIVERSITY OF SOUTHERN CALIFORNIA
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 070189/0456 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 15, 2022
From: HUMAYUN, MARK S.; LAZZI, GIANLUCA; SALHIA, BODOUR; MACHNOOR, MANJUNATH; PAKNAHAD, JAVAD; GONZALEZ-CALLE, ALEJANDRA; TEW, BEN YI
To: UNIVERSITY OF SOUTHERN CALIFORNIA
Reel/Frame 059272/0436 →
Continuity (3)
Provisional Application 63277980 · Nov 10, 2021
Provisional Application 63155715 · Mar 2, 2021
Related Publication 20220280777A1 · Sep 8, 2022
References Cited (16)
US 7877148B2 · Chowdhury et al. · 2011 [cited by applicant]
US 20040106965A1 · Chow · 2004 [cited by examiner]
US 20050010266A1 · Bogdanowicz · 2005 [cited by applicant]
US 20060142857A1 · Chow et al. · 2006 [cited by applicant]
US 20090287275A1 · Suaning et al. · 2009 [cited by applicant]
US 20120130398A1 · Ackermann et al. · 2012 [cited by applicant]
US 20160016014A1 · Wagner · 2016 [cited by examiner]
US 20180078767A1 · Rapoport · 2018 [cited by examiner]
US 20180104475A1 · Ho · 2018 [cited by examiner]
US 20190344076A1 · Irazoqui · 2019 [cited by examiner]
US 20200101290A1 · Rockley · 2020 [cited by examiner]
US 20200171307A1 · Rockley · 2020 [cited by examiner]
US 20210022948A1 · Musallam · 2021 [cited by examiner]
US 20210085977A1 · Chew · 2021 [cited by examiner]
WO WO2020264263A1 · 2020 [cited by examiner]
International Search Report and Written Opinion (mailing date Jun. 15, 2022) for Corresponding International PCT Patent Application No. PCT/US2022/018542, filed Mar. 2, 2022 (7 pages). [cited by applicant]